Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Biamonte
Jacob Daniel Biamonte, Burnaby, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110054876 | PHYSICAL REALIZATIONS OF A UNIVERSAL ADIABATIC QUANTUM COMPUTER - Devices, methods and articles advantageously allow communications between qubits to provide an architecture for universal adiabatic quantum computation. The architecture includes a first coupled basis A | 03-03-2011 |
Jeffrey R. Biamonte, Hyde Park, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090125659 | Inter-Integrated Circuit (12C) Slave with Read/Write Access to Random Access Memory - A program and device for data access via an inter-integrated circuit (I2C) protocol are provided, which includes receiving an I2C read command at an I2C slave device from an I2C master device, and the I2C read command at the I2C slave device is altered such that the I2C read command causes stored data to be read from a storage device, being external to the I2C slave device, in place of reading from internal memory of I2C slave device. An I2C write command having master data and a slave device register address is intended to write to the internal memory of the I2C slave device, and I2C write command at the I2C slave device is altered such that the I2C write command causes the master data to write to the storage device, being external to the I2C slave device, in place of writing to internal memory of the I2C slave device. | 05-14-2009 |
| 20090196295 | ONE OR MORE MULTIPORT SYSTEMS TO FACILITATE SERVICING OF ASYNCRHONOUS COMMUNICATIONS EVENTS - One or more multiport systems are used to facilitate servicing of asynchronous communications events. A multiport system, such as an open collector multiport system, receives from one of a plurality of source components an asynchronous communications event directed to a target component coupled to the plurality of source components. The multiport system is controlled to provide, at any given time, a communications path between a plurality of ports of the multiport system to service the asynchronous communications event. One or more multiport systems are used to forward the event from the source to the target. | 08-06-2009 |
Marco Biamonte, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080255222 | PHARMACEUTICALLY ACTIVE BENZSULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES - The present invention relates to benzsulfonamide derivatives of formula I and methods of use thereof. The benzsulfonamide derivatives of the present invention are efficient modulators of the JNK pathway. In particular the benzsulfonamide derivatives of the present invention are selective inhibitors of JNK 2 and 3. | 10-16-2008 |
| 20090005426 | PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES - Sulfonyl hydrazide compounds according to formula I | 01-01-2009 |
| 20100029719 | ARYLSULFONAMIDE DERIVATIVES AS C-JUN-N-TERMINAL KINASES (JNK'S) INHIBITORS - The present invention relates to sulfonamide derivatives of formula I notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonamide derivatives. Said sulfonamide derivatives are useful in the treatment of neuronal disorders, autoimmune diseases, cancer and cardiovascular diseases. Furthermore, said sulfonamide derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK2 and -3. The present invention is furthermore related to novel sulfonamide derivatives as well as to methods of their preparation. | 02-04-2010 |
Marco Antonio Biamonte, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090318387 | ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS - Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs are described and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents used in the treatment and prevention of various HSP90 mediated disorders. Methods of synthesis and use of such compounds are also described and claimed. | 12-24-2009 |